Clinical Trial Update: Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly Population [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on immunogenicity, safety, and tolerability of a plant-derived quadrivalent influenza vaccine in the elderly.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infections

Drugs mentioned

• Plant-derived seasonal quadrivalent influenza vaccine

Snippet

Sponsor: Medicago | Conditions: Virus Diseases, RNA Virus Infections | Phase 2 | Status: COMPLETED